Category - Precision medicine

Enlightenbio Releases New Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics

Micronoma Raises $3.5 Million in Convertible Note Financing

Exact Sciences To Acquire Ashion Analytics And Enter Research Collaboration With City Of Hope’s Genomics Institute, TGen

Leading Health Providers Unite to Advance Patient Care by Forming Truveta

Personal Genome Diagnostics Announces Close of $103 Million Series C Financing

Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth

Tempus Launches Hereditary Cancer Germline Assay, xG

Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III

Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle

Veracyte to Acquire Decipher Biosciences

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

GATC Health and Liquid Biosciences Partner to Improve Drug Development & Precision Medicine Research

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

Personal Genome Diagnostics and QIAGEN Collaborate to Offer Integrated Genomic Testing and Interpretation Support

Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform

Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancers

Copyright © 2026. enlighenbio LLC. All rights reserved.